血流导向装置治疗颅内动脉瘤的随访:采用三维T1梯度回波双点Dixon成像联合压缩感知三维TOF-MRA评估载瘤动脉通畅性
研究纳入56例血流导向装置治疗的颅内动脉瘤患者,于2020年11月至2021年8月间同时行DSA和3T MRA随访。以DSA为标准,非增强MRA评估载瘤动脉通畅的特异度0.83、阳性预测值0.65,优于增强MRA的0.55和0.41;两者敏感度均为0.93。作者认为非增强MRA可用于无创随访。
要点
- 非增强MRA(LAVA-Flex联合3D-TOF HyperSense)评估载瘤动脉通畅特异度0.83、阳性预测值0.65。
- 增强MRA特异度0.55、阳性预测值0.41,低于非增强MRA。
- 两者敏感度均为0.93,阴性预测值非增强MRA 0.97、增强MRA 0.96。
核心结论
- 非增强MRA可用于血流导向装置治疗颅内动脉瘤的无创随访,LAVA-Flex与3D-TOF HyperSense联合应用可监测载瘤动脉状态和动脉瘤闭塞情况。
研究设计与样本
- 研究纳入56例血流导向装置治疗并于2020年11月至2021年8月间同时行DSA和3T MRA随访的患者,所有患者均采用同一成像方案评估载瘤动脉通畅性,包括DSA、非增强MRA(3D-TOF HyperSense和LAVA-Flex)及增强MRA(时间分辨对比动力学MRA和延迟增强MRA),以DSA为参考标准。
诊断标准与关键数值
- 以DSA为标准评估载瘤动脉通畅性,非增强MRA敏感度0.93、特异度0.83、阳性预测值0.65、阴性预测值0.97。
- 以DSA为标准,增强MRA敏感度0.93、特异度0.55、阳性预测值0.41、阴性预测值0.96。
- 额外置入其他装置的患者及置入特定类型血流导向装置的患者,特异度和阳性预测值倾向于更低。
临床应用与阅片要点
- 非增强MRA(LAVA-Flex联合3D-TOF HyperSense)可用于血流导向装置置入后载瘤动脉通畅性的无创随访评估。
- 联合应用LAVA-Flex和3D-TOF HyperSense序列可监测载瘤动脉状态及动脉瘤闭塞情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: MRA assessment of parent artery patency after flow-diverter placement is complicated by imaging artifacts produced by these devices. The purpose of this study was to assess the accuracy of liver acquisition with volume acceleration-flex technique (LAVA-Flex) MRA in combination with 3D-TOF with HyperSense MRA for the evaluation of parent vessel status after intracranial flow-diverter placement.
MATERIALS AND METHODS: Fifty-six patients treated by flow diversion and followed with both DSA and 3T MRA between November 2020 and August 2021 were included. All patients were evaluated for parent artery patency using the same imaging protocol (DSA, noncontrast MRA including 3D-TOF with HyperSense and LAVA-Flex, and contrast-enhanced MRA, including time-resolved imaging of contrast kinetics MRA and delayed contrast-enhanced MRA).
RESULTS: With DSA as a criterion standard to evaluate the patency of the parent vessel, noncontrast MRA had a good specificity (0.83) and positive predictive value (0.65), better than contrast-enhanced MRA (0.55 and 0.41, respectively). Both had excellent sensitivity and negative predictive value: noncontrast MRA, 0.93 and 0.97, respectively; contrast-enhanced MRA, 0.93 and 0.96, respectively. Specificity and positive predictive value tended to be lower for patients treated with additional devices than for those treated with flow diverters exclusively and for patients treated with a specific type of flow diverter.
CONCLUSIONS: Noncontrast MRA can be used for noninvasive follow-up of intracranial aneurysms treated by flow diverters. The combined use of LAVA-Flex and 3D-TOF with HyperSense sequences allows monitoring the status of the parent artery and aneurysm occlusion.
引用
- Burel, Gerardin, Vannier, et al. Follow-up of Intracranial Aneurysms Treated by Flow Diverters: Evaluation of Parent Artery Patency Using 3D-T1 Gradient Recalled-Echo Imaging with 2-Point Dixon in Combination with 3D-TOF-MRA with Compressed Sensing. AJNR Am J Neuroradiol. 2022. PMID: 35241422. doi:10.3174/ajnr.A7448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。